Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

NCT04388254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Simufilam 100 mg oral tablet
DRUG: Placebo

Sponsor

Cassava Sciences, Inc.

Collaborators

[object Object]